Gaviscon Chewable Tablets Recall: High Magnesium Levels
Sanofi-Aventis recalls Gaviscon chewable tablets due to high magnesium levels. Check lot numbers and expiration dates for affected bottles.
Use caution until it’s fixed
Superpotent Drug: high out-of-specification result for magnesium.
Contact the company
What happened, in plain English
Sanofi-Aventis U.S. LLC is recalling Gaviscon Regular Strength Original Flavor Chewable Tablets because they contain higher-than-specified amounts of magnesium. The affected products are 100-count bottles distributed by GlaxoSmithKline Consumer Healthcare, L.P. This recall involves approximately 2,980 bottles sold nationwide in the USA, Puerto Rico, and the United Kingdom. Read more at govinfonow.com/recall/41565-gaviscon-chewable-tablets-recall-high-magnesium-levels.
Source Summary by GovInfoNow · govinfonow.com/recall/41565-gaviscon-chewable-tablets-recall-high-magnesium-levels · Updated October 11, 2026 · FDA enforcement record: FDA #D-0926-2017
Cite this page
“Gaviscon Chewable Tablets Recall: High Magnesium Levels.” GovInfoNow, updated October 11, 2026. https://govinfonow.com/recall/41565-gaviscon-chewable-tablets-recall-high-magnesium-levels. Based on FDA recall #D-0926-2017 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0926-2017%22&limit=1).
Why it’s dangerous
The tablets have a high out-of-specification result for magnesium, meaning they contain more of the active ingredient than labeled. While the record does not specify immediate symptoms, consuming higher-than-intended doses of magnesium can lead to unintended physiological effects associated with mineral overdose.
Who’s affected
Consumers who purchased Gaviscon Regular Strength Original Flavor Chewable Tablets from retailers in the USA, Puerto Rico, or the United Kingdom. Individuals taking this specific antacid medication are at risk of ingesting incorrect magnesium dosages.
How to tell if you have this one
Look for Gaviscon Regular Strength Original Flavor Chewable Tablets in 100-count bottles with UPC 3 0088-1175-47 8. Check the lot numbers on the packaging; affected lots are 5J69A (Expiration 02/19), 6GF2A, and 6GF3A (Expiration 08/19). The product is distributed by GlaxoSmithKline Consumer Healthcare, L.P., located in Moon Twp, PA.
- Brand
Gaviscon- Product
Gaviscon (Alumina & Magnesium Trisilicate) Regular Strength Original Flavor Chewable Tablets, 80 mg & 14.2 mg- Category
Drug
What to do — step by step
Check Your Product
Verify if your Gaviscon bottles match the affected lot numbers (5J69A, 6GF2A, or 6GF3A) and expiration dates (02/19 or 08/19).
Discontinue Use
Stop using the affected tablets immediately if they match the recalled lot numbers to avoid ingesting excessive magnesium.
Contact Manufacturer
Reach out to Sanofi-Aventis U.S. LLC or GlaxoSmithKline Consumer Healthcare, L.P. for further instructions on returns or refunds.
Where it went and when
Where it was distributed
Distributed nationwide, and outside the U.S.
FDA distribution: “Nationwide in the USA, Puerto Rico, and the United Kingdom.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide, and outside the U.S.
Recall timeline
FDA terminated this recall 20 months after the firm started it.
- Firm started the recall
- FDA classified it Class III
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0926-2017 (June 12, 2017) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0926-2017 to see it in context.
- Plain-language summary written by qwen3.6:35b-a3b on October 11, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.